Latest in News & Research

How Can Dermatology Care Be Improved for Muslim Patients?

Incorporation of religion into cultural humility training recommended, as well as dermatology education at community events

By Dermsquared Editorial Team | | November 15, 2023

Can Mohs Appropriate Use Criteria Score Help Determine Keratinocyte Carcinoma Treatment?

Mohs micrographic surgery was only done on 32.3 percent of the keratinocyte carcinomas that qualified based on AUC score

By Dermsquared Editorial Team | | November 15, 2023

Acupuncture Offers Some Benefit in Chronic Spontaneous Urticaria

However, differences between acupuncture and sham acupuncture, wait-list control did not meet threshold for minimal clinically important difference

By Elana Gotkine (HealthDay News) | | November 14, 2023

Considerable Shortages of Minoxidil Recorded in Greater D.C. Area

Considerable shortages of 2.5, 10 mg minoxidil reported by pharmacies in Washington, D.C., Maryland, and Virginia

By Elana Gotkine (HealthDay News) | | November 09, 2023

Breaking into Dermatology: Tips for NPs & PAs

Why don’t you help Nurse Practitioners and Physician Assistants without dermatology experience find jobs in dermatology?

This is a question we are asked often....

By myDermRecruiter | | November 08, 2023

Does Specialty Training in Dermatopathology Lead to More Severe Diagnoses?

Specialty training linked to increased tendency to diagnose atypical melanocytic proliferations as pT1a melanomas

By Dermsquared Editorial Team | | November 08, 2023

Is There an Increased Risk for Skin Cancer for Older Adults With Actinic Keratoses?

Increased risk seen for any skin cancer, keratinocyte carcinoma, squamous cell carcinoma, basal cell carcinoma, and melanoma

By Dermsquared Editorial Team | | November 08, 2023

AI Getting Better at Detecting Skin Cancer

Software improvements show high sensitivity across skin cancer types, including melanoma

By Lori Solomon (HealthDay News) | | November 03, 2023

Skin Diseases Pose a Psychosocial Burden

Effect seen on patients' daily and work life

By Lori Solomon (HealthDay News) | | November 02, 2023

FDA Approves Wezlana for Multiple Inflammatory Diseases

Approval of the biosimilar allows for interchangeable use with Stelara in both adult and pediatric patients

By Lori Solomon (HealthDay News) | | November 02, 2023

Are Risks for Mortality, MACE, VTE Increased With JAK Inhibitor Use in Skin Conditions?

No increased risk observed for all-cause mortality, MACE, VTE versus placebo/active comparator in dermatologic conditions

By Dermsquared Editorial Team | | November 01, 2023

What Is the Prognostic Significance of Incipient Ulceration in Melanoma?

Patients with nonulcerated tumors have better survival than incipiently ulcerated cases in univariable analysis

By Dermsquared Editorial Team | | November 01, 2023

Lymphoid Reaction Observed in Eczema Patients Receiving Dupilumab

Histopathologic findings included sprinkled distribution of small hyperchromatic lymphocytes in the upper epidermal section

By Elana Gotkine (HealthDay News) | | October 30, 2023

Teens With Atopic Dermatitis More Likely to Experience Bullying

Adolescents with atopic dermatitis have higher odds of being bullied at higher frequency after adjustment for demographics, atopic comorbidities

By Elana Gotkine (HealthDay News) | | October 27, 2023

Nemolizumab Improves Symptoms in Prurigo Nodularis

Treatment efficacy seen in primary end points of itch response and Investigator's Global Assessment response

By Elana Gotkine (HealthDay News) | | October 26, 2023

Tapinarof Cream Safe, Effective for Plaque Psoriasis in Intertriginous Areas

12-week benefits include high rates of skin clearance, meaningful itch relief

By Lori Solomon (HealthDay News) | | October 25, 2023

Do Nutraceutical Supplements Have Beneficial Role in Acne Treatment?

Studies demonstrate potential benefit of vitamins B5 and D, botanical extracts (green tea), probiotics, and ω-3 fatty acids

By Dermsquared Editorial Team | | October 25, 2023

Is Alternative Vismodegib Dosing Regimen Tolerable for Basal Cell Carcinoma?

Alternative regimen of vismodegib 150 mg daily for seven days followed by 21-day drug holiday provides therapeutic effect

By Dermsquared Editorial Team | | October 25, 2023

LAUNCH ALERT: FDA Approves IDP-126 Gel for Acne Vulgaris

The once-daily triple-combination topical acne treatment is approved for use in patients 12 years and older

By Dermsquared Editorial Team | | October 25, 2023

Social Stigma Associated With Adult Facial Acne

Faces with acne rated as less attractive, trustworthy, confident, successful, dominant, and happy

By Lori Solomon (HealthDay News) | | October 20, 2023

LAUNCH ALERT: Bimzelx Approved For Moderate-to-Severe Plaque psoriasis

The groundbreaking injectable biologic agent demonstrates unprecedented efficacy in the treatment of psoriasis.

By Dermsquared Editorial Team | | October 20, 2023

FDA Approves Nivolumab as Adjuvant Treatment for Melanoma

Approval granted for patients aged 12 years and older with stage IIB/C disease

By Lori Solomon (HealthDay News) | | October 18, 2023

Is Nonmelanoma Skin Cancer Causing More Deaths Than Melanoma?

Global melanoma incidence was 324,635 in 2020, resulting in 57,043 deaths, while 63,731 NMSC deaths were reported

By Dermsquared Editorial Team | | October 18, 2023

24 of 1292

Headline from the Week of October 19 - 25, 2026

The Distance Between Habit and Strategy

By Dermsquared Editorial Team | | October 23, 2026

From Poster to Practice: The Control Gap in CIndU

| October 23, 2026